Is discussion of dengue vaccination for the 2016 Olympics necessary?
Lancet
.
2016 Oct 15;388(10054):1880-1881.
doi: 10.1016/S0140-6736(16)31806-2.
Authors
Jose L Arredondo-García
1
,
Sri R S Hadinegoro
2
,
Bruno Guy
3
,
Alain Bouckenooghe
4
,
Fernando Noriega
5
,
Nicholas Jackson
6
Affiliations
1
Instituto Nacional de Pediatria, Mexico City, Mexico.
2
Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia.
3
Sanofi Pasteur, 69367 Lyon CEDEX 07, France. Electronic address:
[email protected]
.
4
Sanofi Pasteur, Singapore.
5
Sanofi Pasteur, Swiftwater, PA, USA.
6
Sanofi Pasteur, 69367 Lyon CEDEX 07, France.
PMID:
27751394
DOI:
10.1016/S0140-6736(16)31806-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Dengue Vaccines
Dengue Virus / immunology
Dengue*
Humans
Vaccination*
Substances
Dengue Vaccines